This Insight Brief explores how biotech is reshaping clinical development through adaptive strategies and evolving business models. As these organizations drive the majority of early drug development and global trial activity, they face increasing pressure from funding constraints, complex regulatory environments and growing competition.

The brief highlights how sponsors are responding with more flexible trial designs, patient-centered approaches and selective application of AI to improve efficiency, accelerate timelines and strengthen decision-making. It also examines shifting global dynamics and the importance of early planning, real-world evidence and strategic partnerships to sustain growth in a highly competitive landscape.

Authored by experts from across IQVIA and the IQVIA Institute for Human Data Science, this resource underscores the need for adaptable, data-driven strategies to successfully advance innovation and bring new therapies to patients worldwide.

Watch the webinar presentation on-demand: https://www.iqviabiotech.com/events/2025/07/emerging-business-models-for-emerging-biopharma-innovation-agility-and-global-impact